Investor Presentaiton slide image

Investor Presentaiton

44 Médica Sur Consolidated Financial Statements and other Integral Results Médica Sur, S.A.B. de C.V. and Subsidiaries Year terms ended on December 31st of 2017 and 2016 (Pesos) Note 2017 Consolidated Cash Flow Statements Médica Sur, S.A.B. de C.V. and Subsidiaries Year terms ended on December 31st of 2017 and 2016 (Pesos) Notes 2017 2017 Annual Report 45 2016 Operation activities cash flow: Net profit Adjustments by: $ 231,870,092 $ 146,210,922 Net cost of the period of employee benefits Depreciation and amortization 13 and 14 (12,759,011) 220,440,656 15,031,944 325,247,154 Transport equipment and other asset sales loss (1,758,707) Profit taxes 2016 Interest in favor 120,428,082 (5,676,881) 107,917 53,519,878 (15,110,169) Financial activities related item Services Income Services Costs Consolidated gross profit $ 3,431,445,846 $ 2,510,362,515 2,268,545,024 1,162,900,822 1,733,753,756 776,608,759 Interest expense Sub total Accounts receivable, net Expenses: Fundación Clínica Médica Sur, A.C.. 141,851,298 694,395,529 (70,427,252) (130,182) 26,877,608 551,885,254 (4,108,574) 95,606 Sales and administration expenses 663,185,180 565,400,468 Other accounts receivable (23,437,105) (42,821,646) Other expenses, net 23 (13,392,260) (4,079,640) Total of expenses 649,792,920 561,320,828 Consolidated operation profit 513,107,902 215,287,931 Income and financial costs (Loss) currency exchange gain, net Interest expenses (268,560) (141,851,298) Interest income Financial Costs, net 24 5,676,881 (136,442,977) 19,718,382 (6,547,897) Consolidated profit before profit taxes, discontinued operations and other integral results 376,664,925 208,740,034 614,576 (26,880,855) Inventories, net Insurance paid in advance Suppliers Taxes and accumulated expenses Contingent liability provisions Net cash flow of operation activities Taxes expenses Interest expenses Net cash flow from operating activities Investment activities: (16,121,154) 1,487,033 (24,208,083) (10,172,043) (55,117,703) (204,087,506) (4,707,748) (7,484,573) 80,594,487 15,436,374 518,456,845 362,613,869 (170,474,322) (143,192,000) (133,996,659) (20,639,728) 213,985,864 198,782,141 Profit taxes 18 120,428,082 55,491,361 Increases in other fixed assets, net Interrupted operation 25 (24,366,751) (7,037,751) Interest received Consolidated net profit 231,870,092 146,210,922 Resources received in real estate, furniture and equipment sales Other integral results: Received deposits 5,676,881 75,944,248 100,454,051 4,837,391 15,110,169 (Losses) actuary profit, net of profit taxes 17 Consolidated Integral Profit (2,090,067) 229,780,025 1,936,970 148,147,892 Real estate, furniture, equipment and investment properties acquisitions Receivable payments or entity share recovery 13 y 14 (266,079,788) (456,700) (230,325,263) Net consolidated profit imputable to: Business acquisitions Controlling share Non-controlling share 231,798,220 71,872 231,870,092 142,634,010 3,576,912 146,210,922 Net cash flow used in investment activities (1,447,493,000) (84,461,308) (1,657,870,703) Financing activities: Integral consolidated profit imputable to: Controlling share Non-controlling share Basic and diluted per share profit Number of average weighted shares See notes attached to the consolidated financial statements 22 $ 229,708,153 71,872 229,780,025 144,570,980 3,576,912 148,147,892 1.88 1.19 123,281,750 $ 123,281,750 Obtained loans 16 Paid dividends 20 Net cash flow (used in) generated by financing activities Cash flow net increase (decrease) and cash equivalents Cash and cash equivalents: 65,000,000 1,285,000,000 (82,137,976) (80,729,079) (17,137,976) 1,204,270,921 112,386,580 (254,817,641) At the beginning of the year At the end of the year 104,310,067 359,127,708 9 $ 216,696,647 $ 104,310,067 See notes attached to the consolidated financial services
View entire presentation